State Street Corporation 13D and 13G filings for Arrowhead Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-05 06:41 am Sale |
2024-12-31 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR |
STATE STREET CORP STT |
6,016,227 4.800% |
-338,104 (-5.32%) |
Filing |
| 2024-10-16 09:15 am Sale |
2024-09-30 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR |
STATE STREET CORP STT |
6,354,331 5.100% |
-470,780 (-6.90%) |
Filing |
| 2024-01-24 12:57 pm Purchase |
2023-12-31 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR |
STATE STREET CORP STT |
6,825,111 6.350% |
854,767 (+14.32%) |
Filing |
| 2023-02-08 10:08 am Purchase |
2022-12-31 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR |
STATE STREET CORP STT |
5,970,344 5.630% |
1,845,874 (+44.75%) |
Filing |